COMMUNIQUÉS West-GlobeNewswire

CurePSP Invests in the Next Generation of PSP and CBD Researchers with Student Fellowship Awards
27/07/2026
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- CurePSP has announced its latest student fellowship recipients, totaling seven projects between the Urso Student Fellowship Grant and the Jim Atwood Neuroscience Student [...]
Vadma Institute Expands Global Practitioner Certification Program as Interest Grows in Its Neuro-Somatic Wellness Method
27/07/2026
Global certification expansion and preliminary HRV-based observational research mark new milestones for the Vadma neuro somatic method Kevin Libawski performs the Vadma neuro-somatic method on clients. LOS ANGELES, July [...]
Applied Biologics Announces Extension of Longstanding System-Wide Agreement With Providence Health & Services for XWRAP®
27/07/2026
SCOTTSDALE, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
HealthEx to Help Americans Bring Their Medical Records into AskMD by Sharecare
27/07/2026
Partnership between Sharecare and HealthEx to support personalized and holistic healthcare navigation in AskMD WASHINGTON, July 27, 2026 (GLOBE NEWSWIRE) -- CMS Health Technology Ecosystem Event – July 27, 2026 – [...]
Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy
27/07/2026
Independent research from a UK group demonstrates durable long-term tissue ablation, while Sonablate’s extensive clinical use reflects its role in advancing HIFU technology worldwide CHARLOTTE, N.C., July 27, 2026 ( [...]
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today provided an update ahead [...]
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
27/07/2026
Collaboration aims to help patients feel more informed, prepared and engaged in their care SUNNYVALE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive [...]
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis
27/07/2026
— Potential first therapy to target chronic Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis — Chronic Pseudomonas is a key driver of inflammation, exacerbations, and disease progression in bronchiectasis — [...]
Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer
27/07/2026
Biopharma Veteran and Former Strategic Advisor Steps Up to Lead Organization as Rose Hill Advances Active Clinical Programs in Psychedelic Therapeutics BOSTON, July 27, 2026 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences [...]
Oktopi secures follow-on funding to expand OktoPilot's AI-informed capabilities, building on the inaugural global health grant
27/07/2026
Grant from the Gates Foundation supports the next phase of work to strengthen OktoPilot's AI-informed capabilities for global health medicine developers MELBOURNE, July 27, 2026 (GLOBE NEWSWIRE) -- Oktopi has received [...]
Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
27/07/2026
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 11, 2026 NASHVILLE, Tenn., July 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease [...]
Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer
27/07/2026
MILLBRAE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet [...]
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
27/07/2026
Dr. Zack brings more than 25 years of leadership in developing therapeutics for immune-mediated diseases Appointment strengthens Spero’s clinical leadership team as the Company advances SP001, a Phase 2-ready third- [...]
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, [...]
FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner
27/07/2026
Exclusive partnership provides 319 Golf Society members with preferred Flyte benefits. FLYTE brings its regional luxury private aviation platform to members of premier private golf clubs across the United States FORT [...]
Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities
27/07/2026
LONG BEACH, Calif. and TORONTO, July 27, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that the Company has retained Matt Murphy, as [...]
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
27/07/2026
BERKELEY HEIGHTS, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage biotechnology company, today announced that [...]
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome
27/07/2026
Transaction to provide Oak Hill Bio with approximately $175 million in gross proceeds, including $75 million of cash in Research Alliance Corporation III’s (Nasdaq: RACC) (“RACC”) trust account that is fully backstopped [...]
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
27/07/2026
LONDON and NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]

Pages